9P First-line (1L) Osimertinib (osi) ± Platinum-Pemetrexed in EGFRm Advanced NSCLC: FLAURA2 Patient-Reported Outcomes (Pros)

C.K. Lee,Y. Cheng,K. Laktionov,S-W. Kim, T. Kato, J. Wang, P. Mitchell, V. Bermudez,S. Kuyama, J.Y. Tan Chun Bing,J.E. Cundom, G.D.J. Pinto,F.A. Shepherd,L. Poole,M. Albayaty, N.P. Amin, K. Kobayashi,L. Havel,J.E. Gray

ESMO Open（2024）

Cited 0|Views14

Key words

Molecular Profiling

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined